Publication | Closed Access

Phase III study of cyclophosphamide, doxorubicin, and etoposide compared with carboplatin and paclitaxel in patients with extensive disease small-cell lung cancer

OncologyMedicinePathologyAnti-cancer AgentPhase Iii StudyLung CancerCancer TreatmentPharmacologyRadiation OncologyChemotherapy